letter . 2026 Mar 19;111(9):3136–3142. doi: 10.3324/haematol.2025.300402
Copyright© 2026 Ferrata Storti Foundation
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Table 1.
Breakdown of the high-dose chemotherapy regimen.
